Head & Neck Oncology Thought Leader Engagement Director

Genmab; Boston (MA); On-site; USD 211,000 - 317,000; Full time

Benefits offered by this job

401(k) match

Health benefits

Parental leave

Wellness programs

Commuter benefits

Tuition reimbursement

Job summary

Genmab is seeking a Director/Associate Director of Thought Leader Engagement for Head & Neck Oncology in the United States. You will lead national engagement with KOLs and Medical Experts, shaping pre-launch and launch strategies for petosemtamab, and coordinating cross-functional efforts across Marketing, Sales, Market Access, and Medical Affairs.

The role requires extensive oncology experience, leadership in cross-functional initiatives, and the ability to travel 50-60% for congresses and

Qualifications

• Requires Bachelor’s degree.
• Significant oncology/biotech experience in a customer-facing role.
• Strong relationships with senior external stakeholders.

Responsibilities

• Develop and lead national thought leader engagement strategy for Head & Neck Oncology.
• Manage KOLs, MEs, and influencers across U.S..
• Lead engagement at oncology congresses and major meetings.
• Recruit, train, and evaluate speaker bureau members.
• Deliver a One Genmab coordinated customer experience across functions.
• Synthesize insights to inform brand strategy and launch readiness.
• Share field insights with cross-functional teams.

Skills

KOL engagement

Oncology marketing

Cross-functional collaboration

Executive influence

Strategic planning

Relationship management

Communication

Stakeholder alignment

Education

Bachelor's degree

Job description

Genmab is seeking a Director/Associate Director of Thought Leader Engagement for Head & Neck Oncology in the United States. You will lead national engagement with KOLs and Medical Experts, shaping pre-launch and launch strategies for petosemtamab, and coordinating cross-functional efforts across Marketing, Sales, Market Access, and Medical Affairs.

The role requires extensive oncology experience, leadership in cross-functional initiatives, and the ability to travel 50-60% for congresses and